Scientists test mRNA tech to reset immune system in autoimmune patients
NCT ID NCT07388212
Summary
This early-stage study is testing a new type of drug that uses mRNA technology (similar to some COVID-19 vaccines) to treat people with autoimmune diseases that have come back or haven't responded to other treatments. The drug is designed to target and remove specific immune cells (B cells and plasma cells) that are thought to drive the disease. The main goals are to find a safe dose and see if the treatment shows any early signs of helping patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.